Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441892 · ClinicalTrials.gov registry record · NA
Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT04441892: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04441892 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04441892, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to further develop and evaluate a diagnostic procedure suitable for use in an inexpensive diagnostic instrument suitable for screening for Long QT Syndrome (LQTS) in the primary care environment.
Interventions
- DEVICE QTc Meter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2020-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04441892
The ClinicalTrials.gov registry entry for NCT04441892 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QTc Meter is the first listed.
NCT04441892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04441892 about?
NCT04441892 is a clinical study titled "Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care". The purpose of this study is to further develop and evaluate a diagnostic procedure suitable for use in an inexpensive diagnostic instrument suitable for screening for Long QT Syndrome (LQTS) in the primary care environment.
What is the current status of trial NCT04441892?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2019-02-07. Estimated completion is 2020-03-26.
What interventions are being tested in trial NCT04441892?
The interventions under investigation include: QTc Meter (DEVICE).
Who is sponsoring clinical trial NCT04441892?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.